{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:45:06Z","timestamp":1790667906629,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T00:00:00Z","timestamp":1601856000000},"content-version":"am","delay-in-days":339,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ejca.2019.08.028","type":"journal-article","created":{"date-parts":[[2019,10,5]],"date-time":"2019-10-05T10:54:17Z","timestamp":1570272857000},"page":"210-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Immune gene expression in head and neck squamous cell carcinoma patients"],"prefix":"10.1016","volume":"121","author":[{"given":"Charlotte","family":"Lecerf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1466-0950","authenticated-orcid":false,"given":"Maud","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Vacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid","family":"Chemlali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Schnitzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9761-0395","authenticated-orcid":false,"given":"Coraline","family":"Dubot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Jeannot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Meseure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerzy","family":"Klijanienko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odette","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Borcoman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7156-9750","authenticated-orcid":false,"given":"Valentin","family":"Calugaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Badois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Chilles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lesnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samar","family":"Krhili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8597-8424","authenticated-orcid":false,"given":"Olivier","family":"Choussy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4430-3439","authenticated-orcid":false,"given":"Caroline","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliane","family":"Piaggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Bieche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Le Tourneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2019.08.028_bib1","series-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN","year":"2012"},{"key":"10.1016\/j.ejca.2019.08.028_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2019.08.028_bib3","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature14129","article-title":"Comprehensive genomic characterization of head and neck squamous cell carcinomas","volume":"517","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2019.08.028_bib4","doi-asserted-by":"crossref","first-page":"47418","DOI":"10.18632\/oncotarget.10163","article-title":"Identification of new candidate therapeutic target genes in head and neck squamous cell carcinomas","volume":"7","author":"Sablin","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2019.08.028_bib5","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejca.2017.12.016","article-title":"Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival","volume":"91","author":"Dubot","year":"1990","journal-title":"Eur J Cancer Oxf Engl"},{"key":"10.1016\/j.ejca.2019.08.028_bib6","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2019.08.028_bib7","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2019.08.028_bib8","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejca.2019.08.028_bib9","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/S1470-2045(16)30066-3","article-title":"Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial","volume":"17","author":"Seiwert","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2019.08.028_bib10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1158\/1078-0432.CCR-05-1886","article-title":"Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers","volume":"12","author":"Badoual","year":"2006","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.ejca.2019.08.028_bib11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1186\/1471-2407-9-292","article-title":"Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinoma","volume":"9","author":"Pretscher","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2019.08.028_bib12","first-page":"6478","article-title":"Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer","volume":"63","author":"Hartmann","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2019.08.028_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/BF01517167","article-title":"Macrophage and dendritic cell infiltration in head and neck squamous-cell carcinoma; an immunohistochemical study","volume":"38","author":"Kerrebijn","year":"1994","journal-title":"Cancer Immunol Immunother CII"},{"key":"10.1016\/j.ejca.2019.08.028_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fimmu.2015.00067","article-title":"Tertiary lymphoid structure-associated B cells are key players in anti-tumor immunity","volume":"6","author":"Germain","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.ejca.2019.08.028_bib15","doi-asserted-by":"crossref","first-page":"e70","DOI":"10.1038\/cti.2016.16","article-title":"OX40, PD-1 and CTLA-4 are selectively expressed on tumor-infiltrating T cells in head and neck cancer","volume":"5","author":"Montler","year":"2016","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.ejca.2019.08.028_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/0471142905.hg1011s57","article-title":"The catalogue of somatic mutations in cancer (COSMIC)","author":"Forbes","year":"2008","journal-title":"Curr Protoc Hum Genet"},{"key":"10.1016\/j.ejca.2019.08.028_bib17","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.eururo.2008.05.027","article-title":"Large-scale real-time reverse transcription-PCR approach of angiogenic pathways in human transitional cell carcinoma of the bladder: identification of VEGFA as a major independent prognostic marker","volume":"56","author":"Pignot","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.ejca.2019.08.028_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"10.1016\/j.ejca.2019.08.028_bib19","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1358330","article-title":"mRNA Expression levels of genes involved in antitumor immunity: identification of a 3-gene signature associated with prognosis of muscle-invasive bladder cancer","volume":"6","author":"Le Goux","year":"2017","journal-title":"OncoImmunology"},{"key":"10.1016\/j.ejca.2019.08.028_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12943-015-0307-3","article-title":"OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy","volume":"14","author":"Shibahara","year":"2015","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ejca.2019.08.028_bib21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","article-title":"Fibroblast heterogeneity and immunosuppressive environment in human breast cancer","volume":"33","author":"Costa","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2019.08.028_bib22","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1093\/annonc\/mdx206","article-title":"Prognostic significance of PD-L1 expression on circulating tumor cells in patients with head and neck squamous cell carcinoma","volume":"28","author":"Strati","year":"2017","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.ejca.2019.08.028_bib23","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.18632\/oncotarget.6429","article-title":"Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma","volume":"7","author":"Darb-Esfahani","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejca.2019.08.028_bib24","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1016\/j.cllc.2016.09.010","article-title":"Association of PD-1, PD-L1, and CTLA-4 gene expression and clinicopathologic\u00a0characteristics in patients with non-small-cell lung cancer","volume":"18","author":"Lafuente-Sanchis","year":"2017","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ejca.2019.08.028_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdy424.045","article-title":"LBA8_PRKEYNOTE-048: phase III study of first-line pembrolizumab (P) for recurrent\/metastatic head and neck squamous cell carcinoma (R\/M HNSCC)","volume":"29","author":"Burtness","year":"2018","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejca.2019.08.028_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1535-6108(02)00030-2","article-title":"Gene expression correlates of clinical prostate cancer behavior","volume":"1","author":"Singh","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2019.08.028_bib27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/bjc.2016.407","article-title":"Perivascular PDGFR-\u03b2 is an independent marker for prognosis in renal cell carcinoma","volume":"116","author":"Fr\u00f6din","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2019.08.028_bib28","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1007\/s12032-012-0193-0","article-title":"PDGFR\u03b2 expression in tumor stroma of pancreatic adenocarcinoma as a reliable prognostic marker","volume":"29","author":"Yuzawa","year":"2012","journal-title":"Med Oncol Northwood Lond Engl"},{"key":"10.1016\/j.ejca.2019.08.028_bib29","series-title":"Abstract P1-07-03: evaluation of the prognostic value of CD3, CD8 and FOXP3 mRNA expression in early breast cancer patients treated with anthracycline-based adjuvant chemotherapy","volume":"vol. 78","author":"Tsiatas","year":"2018"},{"key":"10.1016\/j.ejca.2019.08.028_bib30","doi-asserted-by":"crossref","first-page":"7189","DOI":"10.1158\/0008-5472.CAN-12-4174","article-title":"OX40 is a potent immune-stimulating target in late-stage cancer patients","volume":"73","author":"Curti","year":"2013","journal-title":"Cancer Res"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804919304885?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804919304885?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:26:44Z","timestamp":1760732804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804919304885"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":30,"alternative-id":["S0959804919304885"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2019.08.028","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune gene expression in head and neck squamous cell carcinoma patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2019.08.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}